Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12170046rdf:typepubmed:Citationlld:pubmed
pubmed-article:12170046lifeskim:mentionsumls-concept:C0162522lld:lifeskim
pubmed-article:12170046lifeskim:mentionsumls-concept:C0011777lld:lifeskim
pubmed-article:12170046lifeskim:mentionsumls-concept:C0209210lld:lifeskim
pubmed-article:12170046lifeskim:mentionsumls-concept:C0199176lld:lifeskim
pubmed-article:12170046lifeskim:mentionsumls-concept:C0542559lld:lifeskim
pubmed-article:12170046lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:12170046lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:12170046lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:12170046lifeskim:mentionsumls-concept:C1561560lld:lifeskim
pubmed-article:12170046lifeskim:mentionsumls-concept:C1561561lld:lifeskim
pubmed-article:12170046lifeskim:mentionsumls-concept:C1547135lld:lifeskim
pubmed-article:12170046lifeskim:mentionsumls-concept:C1547139lld:lifeskim
pubmed-article:12170046lifeskim:mentionsumls-concept:C0439841lld:lifeskim
pubmed-article:12170046pubmed:issue6lld:pubmed
pubmed-article:12170046pubmed:dateCreated2002-8-9lld:pubmed
pubmed-article:12170046pubmed:abstractTextPostoperative nausea and vomiting after laparoscopic cholecystectomy remains a common problem despite routine antiemetic prophylaxis. Therefore, the authors investigated the effect of administering 4 mg intravenous dexamethasone as an adjunct to a 5-HT3 antagonist (12.5 mg intravenous dolasetron) with respect to patient outcome.lld:pubmed
pubmed-article:12170046pubmed:languageenglld:pubmed
pubmed-article:12170046pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12170046pubmed:citationSubsetAIMlld:pubmed
pubmed-article:12170046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12170046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12170046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12170046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12170046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12170046pubmed:statusMEDLINElld:pubmed
pubmed-article:12170046pubmed:monthJunlld:pubmed
pubmed-article:12170046pubmed:issn0003-3022lld:pubmed
pubmed-article:12170046pubmed:authorpubmed-author:WhitePaul FPFlld:pubmed
pubmed-article:12170046pubmed:authorpubmed-author:WhittenCharle...lld:pubmed
pubmed-article:12170046pubmed:authorpubmed-author:ColomaMargari...lld:pubmed
pubmed-article:12170046pubmed:authorpubmed-author:ThorntonKevin...lld:pubmed
pubmed-article:12170046pubmed:authorpubmed-author:MarkowitzScot...lld:pubmed
pubmed-article:12170046pubmed:authorpubmed-author:MacalusoAmy...lld:pubmed
pubmed-article:12170046pubmed:authorpubmed-author:BerrisfordSal...lld:pubmed
pubmed-article:12170046pubmed:issnTypePrintlld:pubmed
pubmed-article:12170046pubmed:volume96lld:pubmed
pubmed-article:12170046pubmed:ownerNLMlld:pubmed
pubmed-article:12170046pubmed:authorsCompleteYlld:pubmed
pubmed-article:12170046pubmed:pagination1346-50lld:pubmed
pubmed-article:12170046pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12170046pubmed:meshHeadingpubmed-meshheading:12170046...lld:pubmed
pubmed-article:12170046pubmed:meshHeadingpubmed-meshheading:12170046...lld:pubmed
pubmed-article:12170046pubmed:meshHeadingpubmed-meshheading:12170046...lld:pubmed
pubmed-article:12170046pubmed:meshHeadingpubmed-meshheading:12170046...lld:pubmed
pubmed-article:12170046pubmed:meshHeadingpubmed-meshheading:12170046...lld:pubmed
pubmed-article:12170046pubmed:meshHeadingpubmed-meshheading:12170046...lld:pubmed
pubmed-article:12170046pubmed:meshHeadingpubmed-meshheading:12170046...lld:pubmed
pubmed-article:12170046pubmed:meshHeadingpubmed-meshheading:12170046...lld:pubmed
pubmed-article:12170046pubmed:meshHeadingpubmed-meshheading:12170046...lld:pubmed
pubmed-article:12170046pubmed:meshHeadingpubmed-meshheading:12170046...lld:pubmed
pubmed-article:12170046pubmed:meshHeadingpubmed-meshheading:12170046...lld:pubmed
pubmed-article:12170046pubmed:meshHeadingpubmed-meshheading:12170046...lld:pubmed
pubmed-article:12170046pubmed:meshHeadingpubmed-meshheading:12170046...lld:pubmed
pubmed-article:12170046pubmed:meshHeadingpubmed-meshheading:12170046...lld:pubmed
pubmed-article:12170046pubmed:meshHeadingpubmed-meshheading:12170046...lld:pubmed
pubmed-article:12170046pubmed:meshHeadingpubmed-meshheading:12170046...lld:pubmed
pubmed-article:12170046pubmed:year2002lld:pubmed
pubmed-article:12170046pubmed:articleTitleDexamethasone in combination with dolasetron for prophylaxis in the ambulatory setting: effect on outcome after laparoscopic cholecystectomy.lld:pubmed
pubmed-article:12170046pubmed:affiliationDepartment of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390-9068, USA.lld:pubmed
pubmed-article:12170046pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12170046pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:12170046pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:12170046pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12170046lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12170046lld:pubmed